Skip to main content

Aminolevulinic acid topical Pregnancy and Breastfeeding Warnings

Brand names: Ameluz, Levulan Kerastick

Medically reviewed by Drugs.com. Last updated on Oct 30, 2023.

Aminolevulinic acid topical Pregnancy Warnings

Animal studies have not shown reproductive toxicity. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be given to a pregnant woman only if clearly needed.

US FDA pregnancy category: C

See references

Aminolevulinic acid topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comments:The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. Product Information. Levulan Kerastick (aminolevulinic acid). Berlex Laboratories. 2001;PROD.
  2. Cerner Multum, Inc. UK Summary of Product Characteristics.

References for breastfeeding information

  1. Product Information. Levulan Kerastick (aminolevulinic acid). Berlex Laboratories. 2001;PROD.
  2. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer